These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2079567)

  • 1. Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis.
    Perez V; Tanno H; Villamil F; Fay O
    J Hepatol; 1990; 11 Suppl 1():S113-7. PubMed ID: 2079567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, controlled trial of interferon alfa-2b alone and with simultaneous prednisone for the treatment of chronic hepatitis B. French Multicenter Group.
    Zarski JP; Causse X; Cohard M; Cougnard J; Trepo C
    J Hepatol; 1994 Jun; 20(6):735-41. PubMed ID: 7930473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of high dose interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B: long term follow up.
    Perez V; Findor J; Tanno H; Sordá J
    Gut; 1993; 34(2 Suppl):S91-4. PubMed ID: 8314497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
    Hadziyannis S; Bramou T; Makris A; Moussoulis G; Zignego L; Papaioannou C
    J Hepatol; 1990; 11 Suppl 1():S133-6. PubMed ID: 2079571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
    Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
    N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study.
    Fevery J; Elewaut A; Michielsen P; Nevens F; Van Eyken P; Adler M; Desmet V
    J Hepatol; 1990; 11 Suppl 1():S108-12. PubMed ID: 2079566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial.
    Perrillo RP; Regenstein FG; Peters MG; DeSchryver-Kecskemeti K; Bodicky CJ; Campbell CR; Kuhns MC
    Ann Intern Med; 1988 Jul; 109(2):95-100. PubMed ID: 3289433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a long-term follow-up study.
    Coppens JP; Cornu C; Lens E; Lamy M; Geubel AP
    J Hepatol; 1990; 11 Suppl 1():S126-8. PubMed ID: 2079569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
    Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
    Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
    Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
    Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic hepatitis B with interferon alfa-2b.
    Müller R; Baumgarten R; Markus R; Schulz M; Wittenberg H; Hintsche-Kilger B; Fengler JD; Von Wussow P; Meisel H; Klein H
    J Hepatol; 1990; 11 Suppl 1():S137-40. PubMed ID: 2079572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B.
    Lok AS; Wu PC; Lai CL; Lau JY; Leung EK; Wong LS; Ma OC; Lauder IJ; Ng CP; Chung HT
    Gastroenterology; 1992 Jun; 102(6):2091-7. PubMed ID: 1587429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection.
    Vajro P; Tedesco M; Fontanella A; De Vincenzo A; Vecchione R; Ammendola R; Terracciano LM; Novissimo A; Vegnente A
    Pediatr Infect Dis J; 1996 Mar; 15(3):223-31. PubMed ID: 8852910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-interferon treatment in Chinese patients with chronic hepatitis B.
    Lok AS; Lai CL; Wu PC; Lau JY; Leung EK; Wong LS; Fung YL
    J Hepatol; 1990; 11 Suppl 1():S121-5. PubMed ID: 2079568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.
    Lampertico P; Del Ninno E; Manzin A; Donato MF; Rumi MG; Lunghi G; Morabito A; Clementi M; Colombo M
    Hepatology; 1997 Dec; 26(6):1621-5. PubMed ID: 9398007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study.
    Realdi G; Fattovich G; Pastore G; Caredda F; Noventa F; Santantonio T; Moroni M; Criscuolo D; Maladorno D; Rugge M
    J Hepatol; 1990; 11 Suppl 1():S129-32. PubMed ID: 2079570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long term study of the treatment with recombinant alfa 2b interferon in chronic active hepatitis due to B virus in children and adolescents].
    Castañeda Guillot C; Escobar Capote MD; García Bacallao E; Borbolla Bousquets E
    G E N; 1994; 48(4):219-25. PubMed ID: 7557276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.
    Poynard T; Bedossa P; Chevallier M; Mathurin P; Lemonnier C; Trepo C; Couzigou P; Payen JL; Sajus M; Costa JM
    N Engl J Med; 1995 Jun; 332(22):1457-62. PubMed ID: 7739681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a 10-month follow-up study.
    Coppens JP; Cornu C; Lens E; Lamy M; Geubel A
    Liver; 1989 Oct; 9(5):307-13. PubMed ID: 2685491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.